AlphaQuest’s Integra LifeSciences IART Stock Holding History

AlphaQuest’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,248	Closed	-$65.2K	–	947
2025 Q4	$65.2K	Buy	5,248 +2,843	+118%	+$37.8K	﹤0.01%	1871
2025 Q3	$34.5K	Sell	2,405 -3,584	-60%	-$49.1K	﹤0.01%	2015
2025 Q2	$73.5K	Buy	+5,989	New	+$87K	0.01%	1523
2024 Q4	–	Sell	-14,055	Closed	-$255K	–	1843
2024 Q3	$255K	Buy	+14,055	New	+$326K	0.02%	964
2024 Q2	–	Sell	-17,419	Closed	-$618K	–	1716
2024 Q1	$618K	Buy	17,419 +10,635	+157%	+$425K	0.11%	311
2023 Q4	$295K	Buy	+6,784	New	+$267K	0.06%	532

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AlphaQuest's IART Position: Q1 2026 in Review

AlphaQuest sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 5,248 shares — an estimated $65.2K sold.

AlphaQuest first reported a position in IART in Q4 2023 and held it in 6 quarters. The position peaked at $618K in Q1 2024. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

AlphaQuest reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 5,248 Integra LifeSciences shares in Q1 2026, an estimated $65.2K.
AlphaQuest first reported a position in Integra LifeSciences in Q4 2023 and held it in 6 quarters.
AlphaQuest's Integra LifeSciences position peaked at $618K in Q1 2024.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.